Gene Information |
Gene Symbol |
Tnfrsf1b
|
Synonyms |
CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR, TNFR80, TNFRII, TNFalpha-R2, Tnfr-1, Tnfr2, p75 |
Description |
tumor necrosis factor receptor superfamily, member 1b |
Transcript |
NM_011610
|
Expression |
|
Putative miRNA Targets on Tnfrsf1b |
|
3'UTR of Tnfrsf1b (miRNA target sites are highlighted) |
>Tnfrsf1b|NM_011610|3'UTR
1 CCCCTGACAGGGGTAACACCCTGCAAAGGGACCCCCGAGACCCTGAACCCATGGAACTTCATGACTTTTGCTGGATCCAT
81 TTCCCTTAGTGGCTTCCAGAGCCCCAGTTGCAGGTCAAGTGAGGGCTGAGACAGCTAGAGTGGTCAAAAACTGCCATGGT
161 GTTTTATGGGGGCAGTCCCAGGAAGTTGTTGCTCTTCCATGACCCCTCTGGATCTCCTGGGCTCTTGCCTGATTCTTGCT
241 TCTGAGAGGCCCCAGTATTTTTTCCTTCTAAGGAGCTAACATCCTCTTCCATGAATAGCACAGCTCTTCAGCCTGAATGC
321 TGACACTGCAGGGCGGTTCCAGCAAGTAGGAGCAAGTGGTGGCCTGGTAGGGCACAGAGGCCCTTCAGGTTAGTGCTAAA
401 CTCTTAGGAAGTACCCTCTCCAAGCCCACCGAAATTCTTTTGATGCAAGAATCAGAGGCCCCATCAGGCAGAGTTGCTCT
481 GTTATAGGATGGTAGGGCTGTAACTCAGTGGTCCAGTGTGCTTTTAGCATGCCCTGGGTTTGATCCTCAGCAACACATGC
561 AAAACGTAAGTAGACAGCAGACAGCAGACAGCACAGCCAGCCCCCTGTGTGGTTTGCAGCCTCTGCCTTTGACTTTTACT
641 CTGGTGGGCACACAGAGGGCTGGAGCTCCTCCTCCTGACCTTCTAATGAGCCCTTCCAAGGCCACGCCTTCCTTCAGGGA
721 ATCTCAGGGACTGTAGAGTTCCCAGGCCCCTGCAGCCACCTGTCTCTTCCTACCTCAGCCTGGAGCACTCCCTCTAACTC
801 CCCAACGGCTTGGTACTGTACTTGCTGTGACCCCAAGTGCATGTCCGGGTTAGGCACTGTGAGTTGGAACAGCTGATGAC
881 ATCGGTTGAAAGGCCCACCCGGAAACAGCTGAAGCCAGCTCTTTTGCCAAAGGATTCATGCCGGTTTTCTAATCAACCTG
961 CTCCCCTAGCATGCCTGGAAGGAAAGGGTTCAGGAGACTCCTCAAGAAGCAAGTTCAGTCTCAGGTGCTTGGATGCCATG
1041 CTCACCGATTCCACTGGATATGAACTTGGCAGAGGAGCCTAGTTGTTGCCATGGAGACTTAAAGAGCTCAGCACTCTGGA
1121 ATCAAGATACTGGACACTTGGGGCCGACTTGTTAAGGCTCTGCAGCATCAGACTGTAGAGGGGAAGGAACACGTCTGCCC
1201 CCTGGTGGCCCGTCCTGGGATGACCTCGGGCCTCCTAGGCAACAAAAGAATGAATTGGAAAGGACTGTTCCTGGGTGTGG
1281 CCTCAGCTCCTGTGCTTGTGTGGATCCCTAAAGGGTGTGCTAAGGAGCAATTGCACTGTGTGCTGGACAGAATTCCTGCT
1361 TATAAATGCTTTTTGTTGTTGTTTTGTACACTGAGCCCTGGCTGAGCCACCCCACCCCACCTCCCATCCCACCTTTACAG
1441 CCACTCTTGCAGAGAACCTGGCTGTCTCCCACTTGTAGCCTGTGGATGCTGAGGAAACACCCAGCCAAGTAGACTCCAGG
1521 CTTGCCCCTATCTCCTGCTCTGAGTCTGGCCTCCTCATTGTGTTGTGGGAAGGAGACGGGTTCTGTCATCTCGGAAGCCC
1601 ACACCGTGGATGTGAACAATGGCTGTACTAGCTTAGACCAGCTTAGGGCTCTGCAATCAGAGGAGGGGGAGCAGGGAACA
1681 ATTTGAGTGCTGACCTATAACACATTCCTAAAGGATGGGCAGTCCAGAATCTCCCTCCTTCAGTGTGTGTGTGTGTGTGT
1761 GTGTGTGTGTGTGTGTGTGTGTGTCCATGTTTGCATGTATGTGTGTGCCAGTGTGTGGAGGCCAGAGGTTGGCTTTGGGT
1841 GTGTTTGATCACTCTCAGTTACTGAGGCAGGGCTCTCATCTGTACCCAGAGCTTGCACATTTTCTAGTCTAACTTGCTTC
1921 AGGGATCTCTGTCTGCCTATGGAGTGCTCAGGTTACAGGCAGGCTGCCATACCTGCCCGACATTTACATGAATACTAGAG
2001 ATCTGAATTCTGGTCCTCACACTTGTATACCTGCATTTTATCCACTAAGACATCTCTCCAAGGGCTCCCCCTTCCTATTT
2081 AATAAGTTAGTTTTGAACTGGCAAGATGGCTCAGTGGGTAAGGCAGTTTGCGGACAAACCTGATGACCTGAGTTGGATCC
2161 CTGACCATAAGGTAGAAGAGACCTGATTCCTGCAAGTTGTCCTCTGACCACCACCCCATACATGCTTCTGCATATGTGCA
2241 CACATCACATTCTTGCACACACACTCACATACCATAAATGTAATAAATTTTTTTAAATAAATTGATTTTATCTTTTAATC
2321 ATTATTTTTGCTTATCTGTTTGTTCATACATGGAGTTTTGCTGTATACCCAGTCTGGCTGCATCCTCCAGGCACCTTGAA
2401 CTTGGATATTCTCCTGCCTCAGTTTCGAGAGTGCTGAGTTATAGGCATGTGCAACCGTGTCAGGACCCTTGGCGTTACAT
2481 TATGTTTTCGAATCTTATTTTTCCATCTAAGACTGACAACCACCTTGCCAAAGGATGACCTTGACTTTTGTATCCTCTTG
2561 CCTCTACTTCCCAAGTATTGGGATGACAAGTCTGTCCATCCTATGATTTGTGTGGTGCTGGGGCTTGAACCCAGGGGCCT
2641 CGTGAATGCTAGGCAAACGCAATCAGCTGCCCAACCCCGAACTTCACTTTTCACCTGTGATTTCTTAACATGGTTCCTGA
2721 GCAGACAGCATGATCCTGTTGCCTTGAGGAGCTCTGCTCGTTGCTTTGACAATGCTCTATTTACTAAAGAATACTTATAG
2801 AGTTCAAGACTCCAAAGCAGCAGTTCCCAACCTGTGGGTATGACCTCTTGGGTATCCCATATCAGATATTTACATTAAAC
2881 TTATAACAGAAGCAAAATTACAGTTATGGGGTAGCAACAAAATAATTTTTTTTTGAGGCAGGGTTTATCTGTGTAGCTCA
2961 CTTTGTACAGACTAGGCTGGCCTTGAACTTAAAGATCTGCCTGCCTCTGCCTTCTGAATGCTGGGATTAAATGTGTGTGC
3041 CAACATGCCCAGTGCAGTGAAATAATTTTATTGTTGGGTCACCAAAACATGAGAAAGAGTATTAAAAGGTCATAGCGTTA
3121 GGAAGGTTGAGAACCACTGCCCCAAAAGATAGTAGAAATAGGTAATAGCATTTTAAAAAAAGATTAATTTCTTTTTCCGT
3201 GTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGAAGGGTGCTGAATTCCCTAAATCTGGG
3281 ATTACAGACAATTGTGCCAAATGGGTATTGGGAACCAAAGTTGGGTTTTCTGAAAGAGCAGCAAGTGCCCTTAACTGCTG
3361 AGCCCTCTCTCTAGCTATAATAAACTTTTTTTTAAAAAAATTAAAAAAATTTAGCACTC
Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
miRNA-target interactions (Predicted by miRanda) |
ID |
Duplex structure |
Position |
Score |
MFE |
1
|
miRNA 3' aguguccAAUUUCC-CAGAGUCCCu 5'
|| |:|| ||||||||
Target 5' gccttccTTCAGGGAATCTCAGGGa 3'
|
706 - 730
|
157.00 |
-20.60 |
2
|
miRNA 3' agUGUCCAAUUUCCCAGAGUCCcu 5'
:|| ||| | ||||||||
Target 5' aaGCAAGTTCA---GTCTCAGGtg 3'
|
1007 - 1027
|
143.00 |
-13.90 |
3
|
miRNA 3' agUG-UCCAAUUUCCCAGAGUCCCu 5'
|| || |||:| ||:||||
Target 5' gtACTAGCTTAGACCAGCTTAGGGc 3'
|
1625 - 1649
|
142.00 |
-14.10 |
|
CLIP-seq Support 1 for dataset GSM4656408
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / P7 |
Location of target site |
NM_011610 | 3UTR | AGGGAAUCUCAGGGACUGUAGAGUUCCCAGGCCCCUGCAGCCACCUGUCU |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
CLIP-seq Support 2 for dataset GSM4656408
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / P7 |
Location of target site |
NM_011610 | 3UTR | AGGGAAUCUCAGGGACUGUAGAGUUCCCAGGCCCCUGCAGCCACCUGUCU |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
CLIP-seq Support 3 for dataset GSM4656409
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / Adult |
Location of target site |
NM_011610 | 3UTR | AGGGAAUCUCAGGGACUGUAGAGUUCCCAGGCCCCUGCAGCCACCUGUCUCU |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
CLIP-seq Support 4 for dataset GSM4656409
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / Adult |
Location of target site |
NM_011610 | 3UTR | GCUUCAGGGAUCUCUGUCUGCCUAUGGAGUGCUCAGGUUACAGGCAGGCU |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
CLIP-seq Support 5 for dataset GSM4656410
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / e185 rep2 |
Location of target site |
NM_011610 | 3UTR | AGGGAAUCUCAGGGACUGUAGAGUUCCCAGGCCCCUGCAGCCACCUGUC |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
CLIP-seq Support 6 for dataset GSM4656410
|
Method / RBP |
HITS-CLIP / AGO |
Cell line / Condition |
mouse liver / e185 rep2 |
Location of target site |
NM_011610 | 3UTR | AGGGAUCUCUGUCUGCCUAUGGAGUGCUCAGGUUACAGGCAGGCUGCCA |
Tools used in this analysis |
TargetScan, miRTarCLIP, and Piranha |
Accession Series |
GSE153876 |
CLIP-seq Viewer |
Link |
28 mmu-miR-125a-5p Target Genes:
Functional analysis:
ID |
Target |
Description |
Validation methods |
|
|
Strong evidence |
Less strong evidence |
|
|
|
|
|
|
|
|
MIRT001716 |
Lin28a |
lin-28 homolog A (C. elegans) |
|
|
|
|
|
|
|
|
1 |
1 |
MIRT005597 |
Trim71 |
tripartite motif-containing 71 |
|
|
|
|
|
|
|
|
4 |
3 |
MIRT006310 |
Cbx7 |
chromobox 7 |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT006967 |
4632428N05Rik |
V-set immunoregulatory receptor |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT054177 |
Ptpn18 |
protein tyrosine phosphatase, non-receptor type 18 |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT054178 |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT054179 |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isoform |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT054180 |
Ppp2ca |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform |
|
|
|
|
|
|
|
|
2 |
1 |
MIRT054570 |
Traf6 |
TNF receptor-associated factor 6 |
|
|
|
|
|
|
|
|
3 |
1 |
MIRT580227 |
Tspan12 |
tetraspanin 12 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT582368 |
Mtf1 |
metal response element binding transcription factor 1 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT582450 |
Mgat4a |
mannoside acetylglucosaminyltransferase 4, isoenzyme A |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT584884 |
Antxr2 |
anthrax toxin receptor 2 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT587193 |
Foxk1 |
forkhead box K1 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT588848 |
Snrnp40 |
small nuclear ribonucleoprotein 40 (U5) |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT591275 |
Lars2 |
leucyl-tRNA synthetase, mitochondrial |
|
|
|
|
|
|
|
|
2 |
4 |
MIRT592914 |
Madd |
MAP-kinase activating death domain |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT594893 |
Il1rn |
interleukin 1 receptor antagonist |
|
|
|
|
|
|
|
|
2 |
4 |
MIRT596427 |
Hif1an |
hypoxia-inducible factor 1, alpha subunit inhibitor |
|
|
|
|
|
|
|
|
3 |
3 |
MIRT599142 |
Dqx1 |
DEAQ RNA-dependent ATPase |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT599717 |
Aph1c |
aph1 homolog C, gamma secretase subunit |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT600832 |
Gm14137 |
predicted gene 14137 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT604902 |
Jmy |
junction-mediating and regulatory protein |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT605441 |
Stat1 |
signal transducer and activator of transcription 1 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT606092 |
Wdr25 |
WD repeat domain 25 |
|
|
|
|
|
|
|
|
2 |
2 |
MIRT732537 |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
|
|
|
|
|
|
|
4 |
0 |
MIRT734700 |
VDR |
vitamin D receptor |
|
|
|
|
|
|
|
|
2 |
0 |
MIRT734824 |
Sox11 |
SRY (sex determining region Y)-box 11 |
|
|
|
|
|
|
|
|
2 |
0 |
miRNA-Drug Associations |
miRNA |
Small Melocule |
FDA |
CID |
Detection Method |
Condition |
PMID |
Year |
Expression Pattern of miRNA |
miR-125a |
Budesonide |
approved |
5281004 |
Microarray |
neonatal mice liver |
20145010 |
2010 |
down-regulated |
miR-125a |
Phenethyl isothiocyanate(PEITC) |
NULL |
16741 |
Microarray |
neonatal mice lung |
20145010 |
2010 |
down-regulated |
miR-125a |
Chaihu Shugan San |
NULL |
NULL |
Microarray |
hippocampus |
23947143 |
2013 |
down-regualted |
miR-125a |
Perfluorooctane sulfonate |
NULL |
74483 |
Microarray |
zebrafish embryos |
20878907 |
2011 |
down-regulated |
miR-125a |
Hydroxamic acid HDACi LAQ824 |
NULL |
NULL |
Microarray |
breast cancer cell line SKBr3 |
16452179 |
2006 |
up-regulated |
miR-125a |
Enoxacin |
approved |
3229 |
Quantitative real-time PCR |
HEK293 cells |
18641635 |
2008 |
up-regulated |
miR-125a |
4-hydroxynonenal |
NULL |
5283344 |
Microarray |
human leukemic HL-60 cell |
19022373 |
2009 |
up-regulated |
miR-125a |
Valproate |
approved |
3121 |
Quantitative real-time PCR |
CD4+, CD25- T cells |
20427269 |
2010 |
down-regulated |
miR-125a |
Formaldehyde |
NULL |
712 |
Microarray |
Human lung epithelial cells (A549) |
21147603 |
2011 |
down-regulated |
miR-125a |
Enoxacin |
approved |
3229 |
Northern blot |
HCT-116 and RKO colon cancer cell lines |
21368194 |
2011 |
up-regulated |
miR-125a |
Enoxacin |
approved |
3229 |
Quantitative real-time PCR |
HCT-116 and RKO colon cancer cell lines |
21368194 |
2011 |
up-regulated |
miR-125a |
5-aza-2'-deoxycytidine (5-Aza-CdR) |
approved |
451668 |
Microarray |
breast cancer MDA-MB231 |
22076154 |
2011 |
down-regulated |
miR-125a-5p |
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) |
NULL |
8490 |
Microarray |
mouse brain |
19270793 |
2009 |
up-regulated |
miR-125a-5p |
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) |
NULL |
8490 |
Microarray |
mouse liver |
19270793 |
2009 |
down-regulated |
miR-125a-5p |
Curcumin |
NULL |
969516 |
Microarray |
HONE1 cells |
24896104 |
2014 |
down-regulated |
miR-125a-5p |
5-Fluorouracil |
approved |
3385 |
Microarray |
MCF-7 breast cancer cells |
21506117 |
2011 |
down-regulated |
miR-125a-5p |
Arsenic trioxide |
approved |
14888 |
Quantitative real-time PCR |
acute promyelocytic leukemia |
22072212 |
2012 |
up-regulated |
miR-125a-5p |
Trastuzumab |
approved |
NULL |
Microarray |
SKBR3 cells. |
22384020 |
2012 |
up-regulated |
miR-125a-5p |
Glucocorticoid |
NULL |
NULL |
TaqMan low-density array |
Eosinophilic esophagitis |
22815788 |
2012 |
up-regulated |
miR-125a-5p |
Marine fungal metabolite 1386A |
NULL |
NULL |
Microarray |
MCF-7 breast cancer cells. |
22159329 |
2012 |
down-regulated |
|
miRNA-Drug Resistance Associations |
miRNA |
Drug Name |
CID |
NSC |
FDA |
Effect/Pattern |
Detection Method |
Level |
Phenotype |
Condition |
mmu-miR-125a-5p |
Paclitaxel |
36314 |
NSC125973 |
approved |
sensitive |
|
Low |
Colon Cancer |
tissue and cell line (HT-29) |
|